CNBC July 3, 2024
Good morning!
This Fourth of July week kicked off with some announcements in the neurotech field.
The brain implant startup Paradromics is taking steps to prepare for its first in-human trial next year, and the company announced on Monday that it has launched its official patient registry.
Founded in 2015, Paradromics is building a brain-computer interface, or a BCI, called the Connexus Direct Data Interface. A BCI is a system that deciphers brain signals and translates them into commands for external technologies.
Paradromics’ system will initially serve as an assistive communication device that can turn brain signals into outputs like text or synthesized speech. This means patients with severe paralysis could eventually use it to regain...
Today's Sponsors
Today's Sponsor